Vanderbilt University School of Medicine is a graduate medical school of Vanderbilt University located in Nashville, Tennessee.

During the past decade, Vanderbilt University School of Medicine conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 12 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 7 clinical trials were completed. i.e. 77.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vanderbilt University School of Medicine" #1 sponsor was "Vanderbilt University" with 5 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Glaxo Wellcome" with 4 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials sponsored and "XenoPort, Inc." with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vanderbilt University School of Medicine" #1 collaborator was "Johns Hopkins Bloomberg School of Public Health" with 3 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Vanderbilt University" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Children's Hospitals and Clinics of Minnesota" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Vanderbilt University School of Medicine" are "HIV Infections" (7 trials), "RLS" (3 trials), "Hypothalamic Obesity" (2 trials), "Metastatic Colorectal Cancer" (2 trials) and "Obesity" (2 trials). Many other conditions were trialed in "Vanderbilt University School of Medicine" in a lesser frequency.

Most popular intervention types in "Vanderbilt University School of Medicine" are "Drug" (34 trials), "Biological" (4 trials), "Other" (2 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Zidovudine" (3 trials), "Acyclovir" (2 trials), "Didanosine" (2 trials) and "HORIZANT 300 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Vanderbilt University School of Medicine" are 43 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Vanderbilt University School of Medicine". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 30 completed trials in Vanderbilt University School of Medicine, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Vanderbilt University School of Medicine, 13 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".